Test subjects a major factor in Sinovac Covid-19 vaccine trial result


A health worker shows a vial of Sinovac's Covid-19 vaccine in the Positivo event center at the Barigui Park in Curitiba, Brazil on Jan 28, 2021. - Reuters

PETALING JAYA: Is the Sinovac Covid-19 vaccine 91.2% effective or 50.3% effective in preventing symptoms of this infectious disease?

Interim results from the Phase Three clinical trial in Turkey show the much higher efficacy, while results from the Phase Three trial in Brazil show the latter.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 , Coronavirus , Sinovac , Vaccine , Pharmaniaga

Next In Nation

Sg Golok at Rantau Panjang exceeds alert level
Drugs found during routine luggage check at Subang Air Base, says Khaled
Corruption spreads like a disease when dishonest officers become leaders, says senior cop
Five Air Force officers among 11 nabbed for smuggling drugs via military facilities
Thunderstorm, heavy rain warning issued for nine states until 1am
Malaysia strengthens international cooperation to address climate change at COP31
Faulty extension cord cause of 2025 power disruption at Sabah hospital
Anwar strengthens relations with world leaders, discusses trade, energy
Stop-work order issued on Pontian project over five council violations, foreign waste
Negri's tough year highlights importance of constitutional safeguards, says Tunku Ali

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read